The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2019

Filed:

Feb. 03, 2016
Applicant:

Gmax Biopharm Llc., Hangzhou, CN;

Inventors:

Cheng Zhang, Hangzhou, CN;

Hua Zhang, Hangzhou, CN;

Kesuo Fan, Hangzhou, CN;

Yong Guo, Hangzhou, CN;

Shuqian Jing, Hangzhou, CN;

Assignee:

Gmax Biopharm LLC., Hangzhou, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 9/08 (2006.01); A61K 47/12 (2006.01); C07K 16/28 (2006.01); A61K 38/26 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); C07K 14/605 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39591 (2013.01); A61K 9/08 (2013.01); A61K 38/26 (2013.01); A61K 39/3955 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); C07K 14/605 (2013.01); C07K 16/2869 (2013.01);
Abstract

Disclosed is a stable pharmaceutical solution formulation of a GLP-1R antibody fusion protein, comprising a therapeutically effective amount of the GLP-1R antibody fusion protein, an amino acid, a surfactant and a buffer system. The final concentration of the amino acid is 1-500 mM, the final concentration of the surfactant is 0.01%-0.5%, and the pH value of the stable solution formulation is from 5.0 to 8.0. The stable solution formulation of the present invention can be used in the treatment of diabetes, obesity and conditions associated therewith.


Find Patent Forward Citations

Loading…